^
    3years
    Leica Biosystems strengthens portfolio with FDA clearance of Class II Mismatch Repair (MMR) Panel (PRNewswire)
    "Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers with a high-performing IHC Mismatch Repair (MMR) option when screening colorectal cancer patients for the identification of probable Lynch syndrome."
    FDA event
    |
    BOND MMR Antibody Panel